Enliven Therapeutics, Inc. (ELVN) Technical Analysis
Updated: 2026-05-01 03:19 UTC · Last close: 41.23 (-2.76%) · Support: 37.43
Enliven Therapeutics, Inc. (ELVN) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
37.43
Quick Read
Downside line to hold: 37.43 remains the key nearby support reference.
🔺 Technical Setup
RSI(14)
50.1
📊 Technical Summary
Enliven Therapeutics, Inc. (ELVN) closed at 41.23 (-2.76%). The chart remains in a constructive trend regime, with price holding above both the 50-day and 200-day moving averages. 20-day momentum is notably strong at +9.10%, with price is trading in the upper part of its roughly 52-week range (15.14–48.11), while ATR14 volatility is elevated at roughly 5.54% of price. RSI(14) is 50.1, leaving momentum in a fairly neutral range. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. Initial downside support sits near 37.43. Holding that area would help preserve the current chart structure. Latest fundamentals snapshot: Net income: -103.70M · EPS (basic): -0.32. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
💼 Fundamentals Snapshot
Source: sec
Company
Enliven Therapeutics, Inc.
CIK (SEC ID)
0001672619
Shares Out.
59.26M
Net Income
-103.70M
EPS (Basic)
-0.32
Explore more
Note: This is an algorithmic technical snapshot (not financial advice).